North America Primary Angle-Closure Glaucoma Market is expected to gain significant growth in the forecast period of 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 176.34 million by 2028 from USD 113.24 million in 2020. 

Industry Analysis

Glaucoma is a group of eye conditions that damage the optic nerve, and the proper functioning of the optic nerve is necessary for good vision. This damage is often caused by abnormally high pressure in the eye. The primary angle closure (PAC) is defined as appositional closure of the anterior chamber angle which can lead to aqueous outflow obstruction and raised IOP, in the absence of glaucomatous optic neuropathy. PAC is generally bilateral; a primary angle-closure glaucoma market includes the technique of detection of primary angle-closure glaucoma in early-stage to conduct the future surgical treatment approach which can decrease the blindness rate associated with primary angle closure. The asymptomatic nature of the disease in the early stage causes improper or inaccurate diagnosis of primary angle-closure glaucoma leads to wrong treatment which causes an extra burden on the patient’s pocket and causes a decrease in reliability for the diagnostics product.

Rising prevalence of angle-closure glaucoma and rise in geriatric population are boosting growth of the North America primary angle-closure glaucoma market. However, high surgical cost of PACG and inadequate reimbursement scenario are expected to hamper the market growth in the forecasted period. On the other hand, recent approval of governing bodies and increase of government initiatives towards glaucoma are anticipated to impel the market growth. Lack of skilled professionals and limited access to treatment may act as a challenge for the market growth,

The North America primary angle-closure glaucoma market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.   

North America Primary Angle-Closure Glaucoma Market Scope and Market Size 

 The North America primary angle-closure glaucoma market is segmented on the basis of disease type, type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of disease type, the North America Primary Angle-Closure Glaucoma Market is segmented into acute angle-closure glaucoma and chronic angle-closure glaucoma. In 2021, acute angle-closure glaucoma segment is dominating in the North America Primary Angle-Closure Glaucoma Market owing to the high incidence cases for acute cases.
• On the basis of type, the North America Primary Angle-Closure Glaucoma Market is segmented into diagnosisand treatment. In 2021, diagnosis segment is dominating in the North America Primary Angle-Closure Glaucoma Market due to the primary test and secondary testing options available for the diagnosis and physicians after a proper diagnosis only prefer the medical procedure.
• On the basis of end user, the North America Primary Angle-Closure Glaucoma Market is segmented into hospitals, specialty clinics, ambulatory surgical centersand others. In 2021, hospitals segment is dominating the North America Primary Angle-Closure Glaucoma Market as this segment is specialized in conducting various surgical interventions and has a large professional’s portfolio available for giving the proper treatment.
• On the basis of distribution channel, the North America Primary Angle-Closure Glaucoma Market is segmented into direct tender, retail sales and others. In 2021, direct tender segment dominates the North America Primary Angle-Closure Glaucoma Market as they are the primary source of procurement of diagnostic and surgical devices by healthcare organizations and specialty clinics.

Get Full Access of reports @ https://www.databridgemarketresearch.com/reports/north-america-primary-angle-closure-glaucoma-market

North America Primary Angle-Closure Glaucoma Market Country Level Analysis

The North America primary angle-closure glaucoma market is analysed and market size information is provided product, disease type, type, end user, and distribution channel.

The countries covered in the North America primary angle-closure glaucoma market report are U.S., Canada, and Mexico.

In 2021, U.S. is expected to dominate the market due to the presence of the largest consumer market with high GDP. Moreover, the U.S. has the largest research and development spending in the world and offers trade agreements with several countries making it the largest market for consumer primary angle closure glaucoma diagnosis and surgical products. Canada is expected to showcase substantial growth in the North America market due to increasing economic burden of the country. On the other hand, Mexico is expected to grow in the forecast period of 2021 to 2028 due to rising geriatric population in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Competitive Landscape and North America Primary Angle-Closure Glaucoma Market Share Analysis

North America primary angle-closure glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to primary angle-closure glaucoma market.

The major companies covered in the report are Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.), New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (A Subsidiary of AbbVie Inc.), Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.), Oertli Instrumente AG, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (A Business Unit of Ametek Inc.), and NEW VISION among others.

 MAJOR TOC OF THE REPORT

• Chapter One: Introduction
• Chapter Two: Market Segmentation
• Chapter Three: Market Overview
• Chapter Four: Executive Summary
• Chapter Five: Premium Insights
• Chapter Six: North America Primary Angle-Closure Glaucoma Market by Product & Procedure type

Browse Related Reports @

 About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818  
Email: [email protected]